Bone disease after bone marrow transplantation

Bone Disease of Organ Transplantation

Volumn , Issue , 2005, Pages 339-351

  Ebeling, Peter R ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33444460975     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012183502-6/50020-1     Document Type: Chapter

References (53)

1. Shane E. Transplantation osteoporosis. Osteoporosis: Pathophysiology and Clinical Management 2003, 537-567. Humana Press, Totowa, NJ. E. Orwoll, M. Bliziotes (Eds.).
2. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents on the skeleton. J Bone Miner Res. 1996, 11:1-7.
3. Banfi A., Podesta M., Fazzuoli L., Sertoli M.R., Venturini M., Santini G., Cancedda R., Quarto R. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer. 2001, 92(9):2419-2428.
4. Carlson K., Simonsson B., Ljunghall S. Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int. 1994, 55:408-411.
5. Chaterjee R., Goldstone A.H. Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant. 1996, 17:5-11.
6. Spinelli S., Chiodi S., Bacigalupo A., Brasca A., Menada M.V., Petti A.R., Ravera G., Gualandi F., VanLint M.T., Sessarego M., Frassoni F., Occini D., Lamparelli T., Valeriani A., Oneto R., Vitale V., Corvo R., Marmount A.M. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females. Bone Marrow Transplant. 1994, 14(3):373-380.
7. Tauchmanova L., Selleri C., De Rosa G., Esposito M., Orio F., Palomba S., Bifulco G., Nappi C., Lombardi G., Rotoli B., Colao A. Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. Hum Reprod. 2003, 18(7):1410-1416.
8. Valimaki M., Kinnunen K., Volin L., Tahtela R., Loyttniemi E., Laitinen K., Makela P., Keto P., Ruutu T. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplantation. 1999, 23:355-361.
9. Keilholz U., Max R., Scheibenbogen C., Wuster C., Korbling M., Haas R. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. Cancer 1997, 79:1617-1622.
10. Tauchmanova L., Selleri C., Rosa G.D., Pagano L., Orio F., Lombardi G., Rotoli B., Colao A. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer. 2002, 95(5):1076-1084.
11. Chatterjee R., Mills W., Katz M., McGarrigle H.H., Goldstone A.H. Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients. Bone Marrow Transplant. 1994, 13(5):511-517.
12. Shalet S.M., Didi M., Ogilvy-Stuart A.L., Schulga J., Donaldson M.D. Growth and endocrine function after bone marrow transplantation. Clin Endocrinol (Oxf) 1995, 42(4):333-339.
13. Couto-Silva A.C., Trivin C., Esperou H., Michon J., Fischer A., Brauner R. Changes in height, weight and plasma leptin after bone marrow transplantation. Bone Marrow Transplant. 2000, 26(11):1205-1210.
14. Schulte C., Beelen D., Schaefer U., Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int. 2000, 11:344-353.
15. Rubin M.R., Bilezikian J.P. Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. J Clin Endocrinol Metab. 2002, 87(9):4033-4115.
16. Movsowitz C., Epstein S., Fallon M., Ismail F., Thomas S. Cyclosporin-A in vivo produces severe osteopaenia in the rat: effect of dose and duration of administration. Endocrinology. 1988, 123:2571-2577.
17. Bowman A.R., Sass D.A., Dissanayake I.R., Ma Y.F., Liang H., Yuan Z., Jee W.S., Epstein S. The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res. 1997, 12(4):607-615.
18. Epstein S., Dissanayake A., Goodman G.R., Bowman A., Zhou H., Ma Y., Jee W.S. Effect of the interaction of parathyroid hormone and cyclosporine A on bone mineral metabolism in the rat. Calcif Tissue Int. 2001, 68:240-247.
19. Ebeling P., Thomas D., Erbas B., Hopper L., Szer J., Grigg A. Mechanism of bone loss following allogeneic and autologous hematopoeitic stem cell transplantation. J Bone Miner Res. 1999, 14:342-350.
20. Stern J.M., Sullivan K.M., Ott S.M., Seidel K., Fink J.C., Longton G., Sherrard D.J. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant. 2001, 7(5):257-264.
21. Schimmer A.D., Mah K., Bordeleau L., Cheung A., Ali V., Falconer M., Trus M., Keating A. Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant. 2001, 28(4):387-391.
22. Gandhi M.K., Lekamwasam S., Inman I., Kaptoge S., Sizer L., Love S., Bearcroft P.W., Milligan T.P., Price C.P., Marcus R.E., Compston J.E. Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study. Br J Haematol. 2003, 121(3):462-468.
23. Tauchmanova L., Serio B., Del Puente A., Risitano A.M., Esposito A., De Rosa G., Lombardi G., Colao A., Rotoli B., Selleri C. Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2002, 87(11):5058-5065.
24. Kelly P.J., Atkinson K., Ward R.L., Sambrook P.N., Biggs J.C., Eisman J.A. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation. Transplantation 1990, 50(5):881-883.
25. Nysom K., Holm K., Michaelsen K.F., Hertz H., Jacobsen N., Muller J., Molgaard C. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 2000, 25(2):191-196.
26. Bhatia S., Ramsay N.K., Weisdorf D., Griffiths H., Robison L.L. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998, 22(1):87-90.
27. Kauppila M., Irjala K., Koskinen P., Pulkki K., Sonninen P., Viikari J., Remes K. Bone mineral density after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999, 24(8):885-889.
28. Stern J.M., Chesnut C.H., Bruemmer B., Sullivan K.M., Lenssen P.S., Aker S.N., Sanders J. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 1996, 17(3):395-400.
29. Kashyap A., Kandeel F., Yamauchi D., Palmer J.M., Niland J.C., Molina A., Fung H., Bhatia R., Krishnan A., Nademanee A., O'.Donnell M.R., Parker P., Rodriguez R., Snyder D., Spielberger R., Stein A., Nadler J., Forman S.J. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study. Biol Blood Marrow Transplant 2000, 6(3A):344-351.
30. Schulte C., Beelen D., Schaefer U., Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospectiv estudy. Osteoporosis International 2000, 11:344-353.
31. Kang M.I., Lee W.Y., Oh K.W., Han J.H., Song K.H., Cha B.Y., Lee K.W., Son H.Y., Kang S.K., Kim C.C. The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 2000, 26(3):275-279.
32. Buchs N., Helg C., Collao C., Chapuis B., Slosman D., Bonjour J.P., Rizzoli R. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporos Int. 2001, 12(10):880-886.
33. Lee W.Y., Cho S.W., Oh E.S., Oh K.W., Lee J.M., Yoon K.H., Kang M.I., Cha B.Y., Lee K.W., Son H.Y., Kang S.K., Kim C.C. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab. 2002, 87(1):329-335.
34. Lee W.Y., Kang M.I., Baek K.H., Oh E.S., Oh K.W., Lee K.W., Kim S.W., Kim C.C. The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study. J Korean Med Sci. 2002, 17(6):749-754.
35. Kananen K., Volin L., Tahtela R., Laitinen K., Ruutu T., Valimaki M.J. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 2002, 29(1):33-39.
36. Withold W., Wolf H.H., Kollbach S., Heyll A., Schneider W., Reinauer H. Relationship between bone metabolism and plasma cytokine levels in patients at risk of post-transplantation bone disease after bone marrow transplantation. Eur J Clin Chem Clin Biochem 1996, 34(4):295.
37. Lee W.Y., Kang M.I., Oh E.S., Oh K.W., Han J.H., Cha B.Y., Lee K.W., Son H.Y., Kang S.K., Kim C.C. The role of cytokines in the changes in bone turnover following bone marrow transplantation. Osteoporos Int. 2002, 13(1):62-68.
38. Baek K.H., Lee W.Y., Oh K.W., Kim H.S., Han J.H., Kang M.I., Cha B.Y., Lee K.W., Son H.Y., Kang S.K., Kim C.C. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. J Clin Endocrinol Metab 2004, 89(3):1246-1254.
39. Hamanishi C., Yoshii T., Totani Y., Tanaka S. Bone mineral density of lengthened rabbit tibia is enhanced by transplantation of fresh autologous bone marrow cells. An experimental study using dual X-ray absorptiometry. Clin Orthop. 1994, 303:250-255.
40. Michelson J.D., Gornet M., Codd T., Torres J., Lanighan K., Jones R. Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. Exp Hematol. 1993, 21(3):475-482.
41. Athanasou N.A., Quinn J., Brenner M.K., Prentice H.G., Graham A., Taylor S., Flannery D., McGee J.O. Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation. Br J Cancer 1990, 61(3):385-389.
42. Galotto M., Berisso G., Delfino L., Podesta M., Ottaggio L., Dallorso S., Dufour C., Ferrara G.B., Abbondandolo A., Dini G., Bacigalupo A., Cancedda R., Quarto R. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol. 1999, 27(9):1460-1466.
43. Massenkeil G., Fiene C., Rosen O., Michael R., Reisinger W., Arnold R. Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis. Leukemia 2001, 15(11):1701-1705.
44. Arekat M.R., And G., Lemke S., Moses A.M. Dramatic improvement of BMD following vitamin D therapy in a bone marrow transplant recipient. J Clin Densitom 2002, 5(3):267-271.
45. Hattori M., Morita N., Tsujino Y., Yamamoto M., Tanizawa T. Vitamins D and K in the treatment of osteoporosis secondary to graft-versus-host disease following bone-marrow transplantation. J Int Med Res. 2001, 29(4):381-384.
46. Enright H., Haake R., Weisdorf D. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med. 1990, 89(6):733-738.
47. Tauchmanova L., De Rosa G., Serio B., Fazioli F., Mainolfi C., Lombardi G., Colao A., Salvatore M., Rotoli B., Selleri C. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Cancer 2003, 97(10):2453-2461.
48. Sambrook P. Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation. Calcif Tissue Int. 1999, 65(4):341-343.
49. Meys E., Terreaux-Duvert F., Beaume-Six T., Dureau G., Meunier P.J. Effects of calcium, calcidiol, and monofluorophosphate on lumbar bone mass and parathyroid function in patients after cardiac transplantation. Osteoporosis Int. 1993, 3:329-332.
50. Tauchmanova L., Selleri C., Esposito M., Di Somma C., Orio F., Bifulco G., Palomba S., Lombardi G., Rotoli B., Colao A. Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. Osteoporos Int. 2003, 14(12):1013-1019.
51. Plotkin L.I., Weinstein R.S., Parfitt A.M., Roberson P.I.C., Manolagos S.C., Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999, 104:1363-1374.
52. Castelo-Branco C., Rovira M., Pons F., Duran M., Sierra J., Vives A., Balasch J., Fortuny A., Vanrell J. The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation. Maturitas. 1996, 23(3):307-312.
53. Ebeling P.R., Russell R.G.G. Teriparatide (rhPTH 1-34) treatment of osteoporosis. Inter J Clinical Pract. 2003, 57:710-718.